Form 8.3 - HORIZON THERAPEUTICS PLC – Company Announcement

Form 8.3 - HORIZON THERAPEUTICS PLC

May 31 2023 13:16 BSTSource: RNS

RNS Number : 1949B

Barclays PLC

31 May 2023

FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2007 (AS AMENDED)
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1.				KEY INFORMATION
Name of person dealing (Note 1)				Barclays PLC.
Company dealt in				HORIZON THERAPEUTICS PLC
Class of relevant security to which the dealings being disclosed relate (Note 2)				$0.001 ordinary shares
Date of dealing				30 May 2023
2.				INTERESTS AND SHORT POSITIONS
(a)	Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security:				$0.001 ordinary shares
				Long		Short
				Number	(%)	Number	(%)
(1)	Relevant securities			1,161,213	0.51%	676,818	0.30%
(2)	Derivatives (other than options):			141,886	0.06%	98,064	0.04%
(3)	Options and agreements to purchase/sell:			1,422,500	0.62%	1,185,400	0.52%
TOTAL:				2,725,599	1.19%	1,960,282	0.86%
(b)	Interests and short positions in relevant securities of the company, other than the class dealt in
Class of relevant security:				Long		Short
				Number	(%)	Number	(%)
(1)	Relevant securities
(2)	Derivatives (other than options):
(3)	Options and agreements to purchase/sell:
TOTAL:
3.				DEALINGS (Note 4)
(a)	Purchase and sales
Class of relevant Security			Purchase/sale			Number of securities	Price per unit
$0.001 ordinary shares			Purchase			1	99.7200 USD
$0.001 ordinary shares			Purchase			36	99.6700 USD
$0.001 ordinary shares			Purchase			71	99.5509 USD
$0.001 ordinary shares			Purchase			92	99.5300 USD
$0.001 ordinary shares			Purchase			100	99.5800 USD
$0.001 ordinary shares			Purchase			100	99.5000 USD
$0.001 ordinary shares			Purchase			104	99.4800 USD
$0.001 ordinary shares			Purchase			132	99.5179 USD
$0.001 ordinary shares			Purchase			144	99.3735 USD
$0.001 ordinary shares			Purchase			156	99.4585 USD
$0.001 ordinary shares			Purchase			195	99.5125 USD
$0.001 ordinary shares			Purchase			200	99.4650 USD
$0.001 ordinary shares			Purchase			206	99.4058 USD
$0.001 ordinary shares			Purchase			208	99.5378 USD
$0.001 ordinary shares			Purchase			396	99.3763 USD
$0.001 ordinary shares			Purchase			400	99.5362 USD
$0.001 ordinary shares			Purchase			400	99.5032 USD
$0.001 ordinary shares			Purchase			444	99.5772 USD
$0.001 ordinary shares			Purchase			463	99.5350 USD
$0.001 ordinary shares			Purchase			500	99.5600 USD
$0.001 ordinary shares			Purchase			538	99.4959 USD
$0.001 ordinary shares			Purchase			564	99.3500 USD
$0.001 ordinary shares			Purchase			981	99.5413 USD
$0.001 ordinary shares			Purchase			1,010	99.3793 USD
$0.001 ordinary shares			Purchase			1,615	99.5237 USD
$0.001 ordinary shares			Purchase			1,842	99.5043 USD
$0.001 ordinary shares			Purchase			1,941	99.5634 USD
$0.001 ordinary shares			Purchase			2,023	99.5171 USD
$0.001 ordinary shares			Purchase			2,547	99.5277 USD
$0.001 ordinary shares			Purchase			2,605	99.5717 USD
$0.001 ordinary shares			Purchase			5,575	99.4325 USD
$0.001 ordinary shares			Purchase			5,743	99.4537 USD
$0.001 ordinary shares			Purchase			6,587	99.5281 USD
$0.001 ordinary shares			Purchase			6,598	99.3699 USD
$0.001 ordinary shares			Purchase			9,056	99.5475 USD
$0.001 ordinary shares			Purchase			9,220	99.5091 USD
$0.001 ordinary shares			Purchase			9,512	99.4691 USD
$0.001 ordinary shares			Purchase			17,128	99.5446 USD
$0.001 ordinary shares			Purchase			25,776	99.4613 USD
$0.001 ordinary shares			Sale			4	99.4425 USD
$0.001 ordinary shares			Sale			20	99.3600 USD
$0.001 ordinary shares			Sale			35	99.3845 USD
$0.001 ordinary shares			Sale			37	99.4083 USD
$0.001 ordinary shares			Sale			54	99.4266 USD
$0.001 ordinary shares			Sale			54	99.4800 USD
$0.001 ordinary shares			Sale			100	99.5200 USD
$0.001 ordinary shares			Sale			100	99.3700 USD
$0.001 ordinary shares			Sale			100	99.5000 USD
$0.001 ordinary shares			Sale			200	99.3300 USD
$0.001 ordinary shares			Sale			288	99.4793 USD
$0.001 ordinary shares			Sale			322	99.4300 USD
$0.001 ordinary shares			Sale			519	99.5305 USD
$0.001 ordinary shares			Sale			557	99.5239 USD
$0.001 ordinary shares			Sale			700	99.5042 USD
$0.001 ordinary shares			Sale			700	99.4371 USD
$0.001 ordinary shares			Sale			703	99.4114 USD
$0.001 ordinary shares			Sale			719	99.3581 USD
$0.001 ordinary shares			Sale			800	99.4146 USD
$0.001 ordinary shares			Sale			923	99.3979 USD
$0.001 ordinary shares			Sale			948	99.5481 USD
$0.001 ordinary shares			Sale			963	99.4530 USD
$0.001 ordinary shares			Sale			1,254	99.5733 USD
$0.001 ordinary shares			Sale			2,038	99.5244 USD
$0.001 ordinary shares			Sale			2,142	99.5277 USD
$0.001 ordinary shares			Sale			2,164	99.5488 USD
$0.001 ordinary shares			Sale			5,507	99.3941 USD
$0.001 ordinary shares			Sale			6,171	99.5355 USD
$0.001 ordinary shares			Sale			6,291	99.3500 USD
$0.001 ordinary shares			Sale			7,604	99.3906 USD
$0.001 ordinary shares			Sale			9,474	99.4931 USD
$0.001 ordinary shares			Sale			13,718	99.4786 USD
$0.001 ordinary shares			Sale			50,000	99.5323 USD


(b)	Derivatives transactions (other than option transactions)
Product Name		Nature of transaction				Number of relevant securities	Price per unit



(c)	Options transactions in respect of existing securities
(i)	Writing, selling, purchasing or varying
Class of relevant security	Product description	Writing, purchasing, selling, varying etc	Number of securities to which option relates	Exercise price per unit	Type	Expiry date	Option money paid/ received per unit



(ii)	Exercising
Product name			Number of securities			Exercise price per unit



(d)	Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction				Details		Price per unit (if applicable)

4.				OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
NONE
Is a Supplemental Form 8 (Open Positions) attached?				YES
Date of disclosure:				31 May 2023
Contact name:				Large Holdings Regulatory Operations
Telephone number:				020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL
ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as
appropriate)
OPEN POSITIONS
Class of relevant security		Product Description	Writing, purchasing, selling, varying etc	Number of securities to which option relates	Exercise price per unit	Type	Expiry date
$0.001 ordinary shares		Put Options	Written	495,500	100	American	16 Jun 2023
$0.001 ordinary shares		Put Options	Written	28,800	095	American	21 Jul 2023
$0.001 ordinary shares		Call Options	Written	-10,600	105	American	18 Aug 2023
$0.001 ordinary shares		Put Options	Written	2,000	085	American	21 Jul 2023
$0.001 ordinary shares		Put Options	Purchased	-250,000	080	American	16 Jun 2023
$0.001 ordinary shares		Put Options	Written	10,200	080	American	18 Aug 2023
$0.001 ordinary shares		Put Options	Written	250,000	105	American	16 Jun 2023
$0.001 ordinary shares		Call Options	Written	-2,000	100	American	21 Jul 2023
$0.001 ordinary shares		Call Options	Written	-2,600	100	American	18 Aug 2023
$0.001 ordinary shares		Put Options	Written	74,000	090	American	15 Sep 2023
$0.001 ordinary shares		Put Options	Written	400,000	100	American	18 Aug 2023
$0.001 ordinary shares		Put Options	Purchased	-793,200	080	American	18 Aug 2023
$0.001 ordinary shares		Put Options	Written	162,000	105	American	21 Jul 2023
$0.001 ordinary shares		Put Options	Purchased	-10,200	100	American	18 Aug 2023
$0.001 ordinary shares		Put Options	Purchased	-106,800	090	American	21 Jul 2023
$0.001 ordinary shares		Call Options	Written	-10,000	105	American	16 Jun 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ITPMZGFKMMMGFZM

Company Announcements

Form 8.3 - HORIZON THERAPEUTICS PLC